156 related articles for article (PubMed ID: 7879204)
1. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.
Abramowicz D; Norman DJ; Goldman M; De Pauw L; Kinnaert P; Kahana L; Thistlethwaite JR; Shield CF; Monaco AP; Vanherweghem JL
Transplant Proc; 1995 Feb; 27(1):852-3. PubMed ID: 7879204
[No Abstract] [Full Text] [Related]
2. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch.
Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ
Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808
[No Abstract] [Full Text] [Related]
3. Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
Morales JM; Muñoz MA; Campo C; Andres A; Araque A; Alamo C; Praga M; Ortuño T; Hernandez E; Rodicio JL
Transplant Proc; 1994 Oct; 26(5):2511-2. PubMed ID: 7940770
[No Abstract] [Full Text] [Related]
4. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
[No Abstract] [Full Text] [Related]
5. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.
Howard RJ; Pfaff WW; Brunson ME; Ramos EL; Peterson JC; Croker BP; Scornik JC; Parris CJ; Fennell RS
Transplant Proc; 1993 Feb; 25(1 Pt 2):884. PubMed ID: 8442256
[No Abstract] [Full Text] [Related]
6. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group.
Transplant Proc; 1994 Oct; 26(5):2522-4. PubMed ID: 7940775
[No Abstract] [Full Text] [Related]
7. Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation.
Abouna GM; Kumar MS; Stephan R; Prior JE; Lyons P; Bulova SI; al-Abdullah IH
Transplant Proc; 1993 Jun; 25(3):2241-2. PubMed ID: 8516886
[No Abstract] [Full Text] [Related]
8. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
[TBL] [Abstract][Full Text] [Related]
9. Combined high and low dosing of OKT3 for treatment of rejection episodes in renal transplants.
Schweizer RT; Bartus S; Hull D; Perdrizet G; Roper L
Transplant Proc; 1994 Dec; 26(6):3141. PubMed ID: 7998094
[No Abstract] [Full Text] [Related]
10. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
[No Abstract] [Full Text] [Related]
11. Cyclosporine improves results in HLA-identical sibling renal transplants.
Van Buren D; MacDonell R; Johnson HK; Richie R; Ynares C; Helderman JH; Green W; Crowe D
Transplant Proc; 1994 Oct; 26(5):2514-5. PubMed ID: 7940772
[No Abstract] [Full Text] [Related]
12. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
13. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
14. Strategy for improving retransplantation in the CyA era.
Dickerman R; Langley J; Brinker K; Trevino G; Melton L; Vergne-Marini P; Wilson PK
Transplant Proc; 1993 Feb; 25(1 Pt 1):257-8. PubMed ID: 8438292
[No Abstract] [Full Text] [Related]
15. OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trial.
Höckerstedt K; Ericzon BG; Bismuth H; Chapuis Y; Farges O; Faure JL; Galmarini D; Houssin D; Lynch SV; Miguet J
Transplant Proc; 1993 Feb; 25(1 Pt 1):556-7. PubMed ID: 8438412
[No Abstract] [Full Text] [Related]
16. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
17. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
[TBL] [Abstract][Full Text] [Related]
18. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
[No Abstract] [Full Text] [Related]
19. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
Hiesse C; Rousseau P; Kriaa F; Larue JR; Charpentier B
Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
[No Abstract] [Full Text] [Related]
20. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
